The role of sertraline in the treatment of depression
DOI:
https://doi.org/10.33448/rsd-v11i15.37108Keywords:
Sertraline; Depression; Medication adherence.Abstract
Depression is a disease that affects mental health that basically comes from the modern lifestyle. Several approaches are used to treat depression, from psychotherapy, sport and pharmacological therapies. This study aimed to discuss the use of sertraline to treat depression, pointing out its pharmacodynamics, efficacy and adverse effects. Sertraline belongs to the group of drugs known as selective serotonin reuptake inhibitors (SSRIs) that are commonly prescribed for the treatment of depression, panic attacks, obsessive-compulsive disorders and post-traumatic stress disorder. Treatment with sertraline does not produce significant change in cognitive and psychomotor functions. Through the information collected, it was observed that sertraline has a positive effect in the first six weeks of treatment, especially in relation to the reduction of anxiety. The drug is also effective in the treatment of postpartum depression, being commonly used for this part of the population.
References
Baes, C. V. W. (2016). A neurobiologia da depressão em pacientes com estresse precose: o papel do eixo HPA e da função dos receptores glicocorticóides (GR) e mineralocorticóides (MR) (Doctoral dissertation, Universidade de São Paulo).
Beck, A. T., & Alford, B. A. (2016). Depressão: causas e tratamento. Artmed Editora.
Correia, B. R. (2021). Avaliação do efeito da sertralina sobre os tecidos periodontais de ratos Wistar com periodontite induzida.
Saciente, L., & Batalhão, I. G. (2021). Depressão pós-parto: causas e fatores de risco. Revista Científica, 1(1).
Silva, T. G., de Vasconcelos, P. F., & Moura, I. G. S. (2021). Uma abordagem atual da utilização de antidepressivos no manejo da depressão pós-parto. SMAD, Revista Eletrônica Saúde Mental Álcool e Drogas (Edição em Português), 17(1), 101-108.
Carvalho, L. A. G., Godoy, J. T., Baldo, A. A., Fortes, B. C. R., Lopes, D. C. S., Noia, D. M., & Souza, V. A. (2020). Tratamento farmacológico da depressão em gestantes: uma revisão da literatura. Brazilian Journal of Health Review, 3(4), 10891-10900.
Fann, J. R., Bombardier, C. H., Temkin, N., Esselman, P., Warms, C., Barber, J., & Dikmen, S. (2017). Sertraline for major depression during the year following traumatic brain injury: a randomized controlled trial. The Journal of head trauma rehabilitation, 32(5), 332.
Feng, R., Wang, P., Gao, C., Yang, J., Chen, Z., Yang, Y., & Wang, S. (2018). Effect of sertraline in the treatment and prevention of poststroke depression: A meta-analysis. Medicine, 97(49).
Friedli, K., Guirguis, A., Almond, M., Day, C., Chilcot, J., Da Silva-Gane, M., & Farrington, K. (2017). Sertraline versus placebo in patients with major depressive disorder undergoing hemodialysis: A randomized, controlled feasibility trial. Clinical Journal of the American Society of Nephrology, 12(2), 280-286.
Gilliam, F. G., Black, K. J., Carter, J., Freedland, K. E., Sheline, Y. I., Tsai, W. Y., & Lustman, P. J. (2019). A trial of sertraline or cognitive behavior therapy for depression in epilepsy. Annals of neurology, 86(4), 552-560.
Griciunas, B. W., Kitanishi, N. Y., de Souza, R. C., Cavalcante, D. A., & Marini, L. M. (2017). Síndrome serotoninérgica associada a uso de sertralina: relato de caso. Revista da Faculdade de Ciências Médicas de Sorocaba, 19(2), 100-102.
Hedayati, S. S., Gregg, L. P., Carmody, T., Jain, N., Toups, M., Rush, A. J., & Trivedi, M. H. (2017). Effect of sertraline on depressive symptoms in patients with chronic kidney disease without dialysis dependence: the CAST randomized clinical trial. Jama, 318(19), 1876-1890.
Khouri, A. G., & Santos, S. O. (2019). Inibidores seletivos da recaptação de serotonina: uma opção segura no tratamento da depressão em idosos. Referências em Saúde da Faculdade Estácio de Sá de Goiás-RRS-FESGO, 2(1).
Li, W. H., Wei, Z. W., & Liu, X. F. (2020). Clinical efficacy of sertraline in the treatment of depression caused by Alzheimer disease: A protocol of systematic review. Medicine, 99(45).
Li, Y., Scherer, N., Felix, L., & Kuper, H. (2021). Prevalence of depression, anxiety and post-traumatic stress disorder in health care workers during the COVID-19 pandemic: A systematic review and meta-analysis. PloS one, 16(3), e0246454.
Pavlova, E. L., et al. Transcranial direct current stimulation of 20-and 30-minutes combined with sertraline for the treatment of depression. Progress in Neuro-Psychopharmacology and Biological Psychiatry, 82, 31-38, 2018.
Rodrigues, F. F. A., de Brito, L. R., & de Oliveira Alvim, H. G. (2020). Relação do diabetes mellitus tipo ii com a depressão e o tratamento com antidepressivos. Revista JRG de Estudos Acadêmicos, 3(7), 450-462.
Roveri, L. M., de Freitas, P. L., de Oliveira Sassi, C. R. R., & Donadon, M. L. B. (2019). Tratamento farmacológico da depressão pós-parto. RETEC-Revista de Tecnologias, 12(2).
Sampaio, C. T. L., de Souza Costa, S., Marques, C. P. C., Júnior, N. D. J. P. B., Costa, I. S., de Sousa, J. R., & Victor, Y. A. (2022). Depressão e suicídio em médicos no Brasil: uma revisão integrativa 2013-2021. Research, Society and Development, 11(1), e52711125264-e52711125264.
Thiollent, M. (2022). Metodologia da pesquisa-ação. Cortez editora.
Vargas, I. M., Martins, P. S., & de Oliveira Marquez, C. (2022). A contribuição do farmacêutico no tratamento farmacológico da depressão: uma revisão. Scire Salutis, 12(1), 74-81.
Zahed, N. S., Sharifi, M., Karimi, M., & Nikbakht, H. (2017). Impact of sertraline on serum concentration of CRP in hemodialysis patients with depression. Journal of Renal Injury Prevention, 6(1), 65.
Zhang, S., Liu, X., Sun, M., Zhang, Q., Li, T., Li, X., & Feng, X. (2018). Reversal of reserpine-induced depression and cognitive disorder in zebrafish by sertraline and Traditional Chinese Medicine (TCM). Behavioral and Brain Functions, 14(1), 1-14.
Downloads
Published
How to Cite
Issue
Section
License
Copyright (c) 2022 Sabrina Cristina Vaz; Isabella Cristina de Souza Luz; Anthony Alves dos Santos ; Alana Ferreira Nunes; Luana Alves de Freitas Afiune
This work is licensed under a Creative Commons Attribution 4.0 International License.
Authors who publish with this journal agree to the following terms:
1) Authors retain copyright and grant the journal right of first publication with the work simultaneously licensed under a Creative Commons Attribution License that allows others to share the work with an acknowledgement of the work's authorship and initial publication in this journal.
2) Authors are able to enter into separate, additional contractual arrangements for the non-exclusive distribution of the journal's published version of the work (e.g., post it to an institutional repository or publish it in a book), with an acknowledgement of its initial publication in this journal.
3) Authors are permitted and encouraged to post their work online (e.g., in institutional repositories or on their website) prior to and during the submission process, as it can lead to productive exchanges, as well as earlier and greater citation of published work.
